The skin and hair-related research interest in GLOW comes mainly from its GHK-Cu component
Anti-inflammatory properties: Switzerland Studies suggest the peptide exhibits anti-inflammatory effects by modulating cytokines, which play a key role in the bodys inflammatory response to injury or disease (2)
Precedent in Animal Research: Multiple animal model studies have used oral administration of BPC-157, demonstrating biological effects through this route in controlled laboratory conditions
Important limitation: Neither is FDA-approved, and human clinical data relies heavily on animal models and observational reports
This stability has allowed researchers to study the compound through multiple administration routes in preclinical settings, making it easier to examine its systemic effects across organ systems
Monitoring: Depending on the peptide and its intended use, your healthcare provider may recommend regular monitoring of certain health parameters, such as hormone levels or blood markers